Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats

Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

Baert, F. J., D’Haens, G., Peeters, M., Hiele, M. I., Schaible, T. F., Shealy, D. J., Geboes, K. J., & Rutgeerts, P. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70224-6 · Cited by 460 · see citing works

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

González-Gay, M. Á., Matias, J. M. D., González‐Juanatey, C., Garcı́a-Porrúa, C., Sanchez-Andrade, A., Martin, J. J., & Llorca, J. (2006) · PubMed · Cited by 313 · see citing works

mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats

Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., & Koide, H. (1993) · Diabetes · doi:10.2337/diab.42.3.450 · Cited by 307 · see citing works

Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression

Wolfe, F., & Sharp, J. T. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 274 · see citing works

Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy

Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270 · see citing works

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268 · see citing works

Inhibition of endogenous TNF formation by pentoxifylline

Zabel, P., Schade, F. U., & Schlaak, M. S. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80356-6 · Cited by 183 · see citing works

Role of p38 Mitogen-Activated Protein Kinase Activation in Podocyte Injury and Proteinuria in Experimental Nephrotic Syndrome

Koshikawa, M., Mukoyama, M., Mori, K., Suganami, T., Sawai, K., Yoshioka, T., Nagae, T., Yokoi, H., Kawachi, H., Shimizu, F., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121084 · Cited by 172 · see citing works

Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats

Kalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 154 · see citing works

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli

Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 151 · see citing works

Tumor necrosis factor-α gene expression in diabetic nephropathy: Relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition

Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & Garcı́a, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 145 · see citing works

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration

Navarro‐González, J. F., Fernández, C. M., Rivero, A., Gallego, E., Chahin, J., Macia, M. L., Méndez, M. L., & García, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70182-4 · Cited by 143 · see citing works

Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy

Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., & Kawashima, S. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045634 · Cited by 121 · see citing works

Changes in Spontaneous Behavior in Rats Exposed to Experimental Disc Herniation are Blocked by Selective TNF-Alpha Inhibition

Olmarker, K., Nutu, M., & Størkson, R. (2003) · Spine · doi:10.1097/01.brs.0000083162.35476.ff · Cited by 113 · see citing works

Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation

Yamamoto, N., Sakai, F., Yamazaki, H., Nakahara, K., & OKUHARA, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00537-7 · Cited by 103 · see citing works

Pentoxifylline Ameliorates Renal Tumor Necrosis Factor Expression, Sodium Retention, and Renal Hypertrophy in Diabetic Rats

DiPetrillo, K., & Gesek, F. A. (2004) · American Journal of Nephrology · doi:10.1159/000079121 · Cited by 87 · see citing works

FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shock

Yamamoto, N., Sakai, F., Yamazaki, H., Sato, N., Nakahara, K., & OKUHARA, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)89657-4 · Cited by 73 · see citing works

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.

Guerrero‐Romero, F., Rodríguez‐Morán, M., Paniagua-Sierra, J. R., García-Bulnes, G., Salas-Ramírez, M., & Amato, D. (1995) · PubMed · Cited by 65 · see citing works

The specific p38 mitogen-activated protein kinase pathway inhibitor FR167653 keeps insulitis benign in nonobese diabetic mice

Ando, H., Kurita, S., & Takamura, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.045 · Cited by 18 · see citing works

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

Navarro‐González, J. F., Fernández, C. M., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,073 · see citing works

The Role of Inflammatory Cytokines in Diabetic Nephropathy

Navarro‐González, J. F., & Fernández, C. M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 936 · see citing works

Inflammation and the pathogenesis of diabetic nephropathy

Wada, J., & Makino, H. (2012) · Clinical Science · doi:10.1042/cs20120198 · Cited by 776 · see citing works

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432 · see citing works

Oxidative Stress in Diabetes: Implications for Vascular and Other Complications

Pitocco, D., Tesauro, M., Rizzi, A., Ghirlanda, G., & Cardillo, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121525 · Cited by 409 · see citing works

Apoptotic cell death in disease—Current understanding of the NCCD 2023

Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 359 · see citing works

Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes

Gohda, T., Niewczas, M. A., Ficociello, L., Walker, W. H., SKUPIEN, J. K., Rosetti, F., Culleré, X., Johnson, A. C., Crabtree, G. S., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 357 · see citing works

Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets

Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.016 · Cited by 340 · see citing works

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

Rayego‐Mateos, S., Morgado‐Pascual, J. L., Opazo-Ríos, L., Guerrero‐Hue, M., García‐Caballero, C., Vázquez‐Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 342 · see citing works

The next generation of therapeutics for chronic kidney disease

Breyer, M. D., & Suszták, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 274 · see citing works

Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update

Arora, M. K., & Singh, U. K. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.01.001 · Cited by 241 · see citing works

TNF receptors: signaling pathways and contribution to renal dysfunction

Al‐Lamki, R. S., & Mayadas, T. N. (2014) · Kidney International · doi:10.1038/ki.2014.285 · Cited by 215 · see citing works

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

Toth‐Manikowski, S. M., & Atta, M. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/697010 · Cited by 196 · see citing works

Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats

Pan, Y., Wang, Y., Cai, L., Cai, Y., Hu, J., Yu, C., Li, J., Feng, Z., Yang, S., Li, X., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01854.x · Cited by 176 · see citing works

Therapeutic approaches to diabetic nephropathy—beyond the RAS

Fernández‐Fernández, B., Ortíz, A., Gómez‐Guerrero, C., & Egido, J. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.74 · Cited by 169 · see citing works

Targeting inflammation in diabetic nephropathy: a tale of hope

Moreno, J. A., Gómez‐Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, Ó., Ruiz‐Ortega, M., Opazo-Ríos, L., Mezzano, S. A., & Egido, J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1538352 · Cited by 170 · see citing works

Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target

Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164 · see citing works

Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy

Moon, J.-Y., Jeong, K. H., Lee, T., Ihm, C., Lim, S. J., & Lee, S. H. (2012) · American Journal of Nephrology · doi:10.1159/000334928 · Cited by 161 · see citing works

Inflammation in diabetic kidney disease

García-García, P. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.431 · Cited by 154 · see citing works

Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis

Nørregaard, R., Mutsaers, H. A. M., Frøkiær, J., & Kwon, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00027.2022 · Cited by 146 · see citing works

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy

Luis-Rodríguez, D. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.7 · Cited by 132 · see citing works

Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment

Barutta, F., Bruno, G., Grimaldi, S., & Gruden, G. (2014) · Endocrine · doi:10.1007/s12020-014-0437-1 · Cited by 125 · see citing works

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

Awad, A. S., Kinsey, G. R., Khutsishvili, K., Gao, T., Bolton, W. K., & Okusa, M. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00332.2011 · Cited by 123 · see citing works

The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications

Dal-Ros, S., & Sigrist, S. (2016) · Diseases · doi:10.3390/diseases4030024 · Cited by 112 · see citing works

Effect of pomegranate juice on Angiotensin II‐induced hypertension in diabetic wistar rats

Mohan, M., Waghulde, H., & Kasture, S. B. (2009) · Phytotherapy Research · doi:10.1002/ptr.3090 · Cited by 95 · see citing works

Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy

Navarro‐González, J. F., Jarque, A., Muros, M., Fernández, C. M., & Garcı́a, J. G. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.005 · Cited by 89 · see citing works

Role of the Immune System in Diabetic Kidney Disease

Hickey, F. B., & Martin, F. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0984-6 · Cited by 88 · see citing works

Role of the TNF pathway in the progression of diabetic nephropathy in KK-Aymice

Omote, K., Gohda, T., Murakoshi, M., Sasaki, Y., Kazuno, S., Fujimura, T., Ishizaka, M., Sonoda, Y., & Tomino, Y. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00509.2013 · Cited by 78 · see citing works

Kidney Proximal Tubular Epithelial-Specific Overexpression of Netrin-1 Suppresses Inflammation and Albuminuria through Suppression of COX-2-Mediated PGE2 Production in Streptozotocin-Induced Diabetic Mice

Mohamed, R., Jayakumar, C., Ranganathan, P. V., Ganapathy, V., & Ramesh, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.014 · Cited by 77 · see citing works

Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism

Balakumar, P., Arora, M. K., Reddy, J., & Anand‐Srivastava, M. B. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181ad2190 · Cited by 70 · see citing works

Diabetic kidney disease and immune modulation

Hickey, F. B., & Martin, F. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.002 · Cited by 69 · see citing works

Cytokines in diabetic nephropathy

Wu, C., Sytwu, H., & Lin, Y. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00014-5 · Cited by 67 · see citing works

Different Roles of Mast Cells in Obesity and Diabetes: Lessons from Experimental Animals and Humans

Shi, M. A., & Shi, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00007 · Cited by 66 · see citing works

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease

Murakoshi, M., Gohda, T., & Suzuki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061957 · Cited by 62 · see citing works

Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy

Tramonti, G., & Kanwar, Y. S. (2012) · Endocrine · doi:10.1007/s12020-012-9820-y · Cited by 60 · see citing works

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy

Gurley, S. B., Ghosh, S., Johnson, S. A., Azushima, K., Sakban, R. B., George, S. E., Maeda, M., Meyer, T. W., & Coffman, T. M. (2018) · Diabetes · doi:10.2337/db17-1323 · Cited by 59 · see citing works

Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice

Liu, W., Chen, X., Wang, Y., Chen, Y., Chen, S., Gong, W., Chen, T., Sun, L., Zheng, C., Yin, B., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104506 · Cited by 59 · see citing works

Ginsenoside Rh1 Improves Type 2 Diabetic Nephropathy through AMPK/PI3K/Akt-Mediated Inflammation and Apoptosis Signaling Pathway

Su, W.-Y., Li, Y., Xuan, C., Li, X., Wei, H., Liu, Z., Shen, Q. “., Chen, C., Wang, Y., & Li, W. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500580 · Cited by 58 · see citing works

Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model

Hofherr, A., Williams, J. H., Gan, L., Söderberg, M. P., Hansen, P., & Woollard, K. J. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02794-8 · Cited by 60 · see citing works

The effect of <scp>GLP</scp> ‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis

Ren, Y., Chen, Y., Zheng, W., Kong, W., Liao, Y., Zhang, J., Wang, M., & Zeng, T. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16366 · Cited by 59 · see citing works

Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats

Leehey, D. J., Singh, A. K., Bast, J. P., Sethupathi, P., & Singh, R. (2008) · Translational research · doi:10.1016/j.trsl.2008.01.003 · Cited by 56 · see citing works

Structural damage in diabetic nephropathy is associated with TNF-α system activity

Fernández‐Real, J. M., Vendrell, J. J., García, I., Ricart, W., & Vallés, M. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0349-y · Cited by 56 · see citing works

Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease

Kim, H., Lee, C., Cha, H., Choe, J., Park, E., & Kim, J. (2014) · Rheumatology International · doi:10.1007/s00296-014-3146-4 · Cited by 55 · see citing works

Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin^|^ndash;Angiotensin System Activation in Experimental Type 1 Diabetes

Kamiyama, M., Zsombok, A., & Kobori, H. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12076fp · Cited by 53 · see citing works

The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD

Lousa, I., Reis, F., Santos‐Silva, A., & Belo, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063284 · Cited by 57 · see citing works

TNF-α, Erectile Dysfunction, and NADPH Oxidase-Mediated ROS Generation in Corpus Cavernosum in High-Fat Diet/Streptozotocin-Induced Diabetic Rats

Long, T., Liu, G., Wang, Y., Chen, Y., Zhang, Y., & Qin, D. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02739.x · Cited by 53 · see citing works

Epigenetics and Inflammation in Diabetic Nephropathy

Shao, B., Zhang, S., Li, H.-D., Meng, X., & Chen, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649587 · Cited by 52 · see citing works

Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics

Zhang, H., Zhao, T., Gong, Y., Dong, X., Zhang, W., Sun, S., Wang, H., Gu, Y., Lu, X., Yan, M., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.020 · Cited by 50 · see citing works

Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy

Chung, C. H., Fan, J., Lee, E. Y., Kang, J. S., Lee, S. J., Pyagay, P. E., Khoury, C. C., Yeo, T.-K., Khayat, M. F., Wang, A., et al. (2015) · Nephron Extra · doi:10.1159/000369576 · Cited by 49 · see citing works

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy

Sabapathy, V., Stremska, M. E., Mohammad, S., Corey, R. L., Sharma, P. R., & Sharma, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00572 · Cited by 48 · see citing works

A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy

Tziastoudi, M., Stefanidis, I., Hadjigeorgiou, G. M., STRAVODIMOS, K. G., & Zintzaras, E. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx008 · Cited by 48 · see citing works

FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells

Jung, D.-S., Li, J. J., Kwak, S.-J., Lee, S. H., Park, J., Song, Y. S., Yoo, T., Han, S. H., Lee, J. E., Kim, D. K., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00624.2007 · Cited by 44 · see citing works

Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease

Bae, E., Cha, R., Kim, Y. C., An, J. N., Kim, D. K., Yoo, K. D., Lee, S. M., Kim, M.-H., Park, J. T., Kang, S., et al. (2017) · Medicine · doi:10.1097/md.0000000000006666 · Cited by 43 · see citing works

A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration

Fang, Q., Zhao, L., Wang, Y., Zhang, Y., Li, Z., Pan, Y., Kanchana, K., Wang, J., Tong, C., Li, D., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.10.021 · Cited by 41 · see citing works

Present and Future in the Treatment of Diabetic Kidney Disease

Quiroga, B., Arroyo, D., & de Arriba, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/801348 · Cited by 40 · see citing works

Soluble TNF Receptors and Kidney Dysfunction in the Elderly

Carlsson, A. C., Larsson, T. E., Helmersson‐Karlqvist, J., Larsson, A. O., Lind, L., & Ärnlöv, J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080860 · Cited by 36 · see citing works

More Questions Than Answers: A Call for a Moratorium on the Use of Intravitreal Infliximab Outside of a Well-Designed Trial

Pulido, J. S., Pulido, J. S., Michet, C. J., & Vile, R. G. (2010) · Retina · doi:10.1097/iae.0b013e3181cde727 · Cited by 35 · see citing works

Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy

Chadha, G., & Morris, M. E. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0048-z · Cited by 35 · see citing works

Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy

Ma, L., Liu, D., Yu, Y., Li, Z., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1587806 · Cited by 32 · see citing works

Can C‐peptide mediated anti‐inflammatory effects retard the development of microvascular complications of type 1 diabetes?

Luppi, P., Kallas, Å., & Wahren, J. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2409 · Cited by 29 · see citing works

Biomarkers in diabetic nephropathy: A comprehensive review of their role in early detection and disease progression monitoring

Wani, Z. A., Ahmed, S., Saleh, A., Anna, V. R., Fahelelbom, K. M., Raju, S. K., Abu‐Rayyan, A., & Bhat, A. R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112292 · Cited by 28 · see citing works

Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials

Atkin, S. L., Katsiki, N., Banach, M., Mikhailidis, D. P., Pirro, M., & Sahebkar, A. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.016 · Cited by 27 · see citing works

Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes

Rosa, A. C., Rattazzi, L., Miglio, G., Collino, M., & Fantozzi, R. (2012) · Inflammation Research · doi:10.1007/s00011-011-0412-8 · Cited by 27 · see citing works

Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats

Abdelrahman, A. M., Suleimani, Y. M. A., Manoj, P., Ashique, M., Ali, B. H., & Schupp, N. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01719-x · Cited by 26 · see citing works

Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals

Carlsson, A. C., Nordquist, L., Larsson, T. E., Carrero, J. J., Larsson, A. O., Lind, L., & Ärnlöv, J. (2015) · Cardiorenal Medicine · doi:10.1159/000435863 · Cited by 25 · see citing works

Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?

Balakumar, P., Reddy, J., & Singh, M. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0132-3 · Cited by 25 · see citing works

A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-Ay Type 2 Diabetic Mice and Diabetic Peripheral Neuropathy in Type 1 Diabetic Mice

Maekawa, M., Tadaki, H., Tomimoto, D., Okuma, C., Sano, R., Ishii, Y., Katsuda, Y., Yoshiuchi, H., Kakefuda, R., Ohta, T., et al. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00526 · Cited by 23 · see citing works

Podocyte derived TNF ‐α mediates monocyte differentiation and contributes to glomerular injury

Nishad, R., Mukhi, D., Kethavath, S., Raviraj, S., Paturi, A. S. V., Motrapu, M., Kurukuti, S., & Pasupulati, A. K. (2022) · The FASEB Journal · doi:10.1096/fj.202200923r · Cited by 22 · see citing works

Advances in understanding the innate immune‐associated diabetic kidney disease

Wan, S., Wan, S., Jiao, X., Cao, H., Gu, Y., Yan, L., Zheng, Y., Niu, P., & Shao, F. (2021) · The FASEB Journal · doi:10.1096/fj.202002334r · Cited by 22 · see citing works

Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats

Abdelrahman, A. M., Suleimani, Y. M. A., Shalaby, A. A., Ashique, M., Manoj, P., & Ali, B. H. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01655-w · Cited by 21 · see citing works

Lipids: A Major Culprit in Diabetic Nephropathy

Beniwal, A., Jain, J. C., & Jain, A. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998259273231101052549 · Cited by 21 · see citing works

Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?

Nordquist, L. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3955 · Cited by 21 · see citing works

Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat

Slyvka, Y., Inman, S. R., Malgor, R., JACKSON, E. J., Yee, J., Oshogwemoh, O., Adame, J. D., & Nowak, F. V. (2008) · Endocrine · doi:10.1007/s12020-008-9121-7 · Cited by 20 · see citing works

Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-α system

Ng, D., Fukushima, M., Tai, B. C., Koh, D. S. Q., Leong, H., Imura, H., & Lim, X.-L. (2008) · Diabetologia · doi:10.1007/s00125-008-1162-1 · Cited by 20 · see citing works

Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options

López-Parra, V., Mallavia, B., Egido, J., & Gómez‐Guerrero, C. (2012) · InTech eBooks · doi:10.5772/34541 · Cited by 19 · see citing works

Molecular Therapeutics for Diabetic Kidney Disease: An Update

Guo, M., He, F.-F., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810051 · Cited by 18 · see citing works

New approaches to the treatment of nephropathy in diabetes

Thomas, M. C., & Groop, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.591785 · Cited by 17 · see citing works

Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?

Leehey, D. J. (2020) · Kidney360 · doi:10.34067/kid.0001252019 · Cited by 17 · see citing works

Identification of key immune‐related genes and immune infiltration in diabetic nephropathy based on machine learning algorithms

Sun, Y., Dai, W., & He, W. (2023) · IET Systems Biology · doi:10.1049/syb2.12061 · Cited by 15 · see citing works

Predictors of the early impairment of renal disease in human obesity

Gilardini, L., Zulian, A., Girola, A., Redaelli, G., Conti, A., & Invitti, C. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.227 · Cited by 15 · see citing works

Enhanced Apoptosis of Monocytes from Complication-Free Juvenile-Onset Diabetes Mellitus Type 1 May Be Ameliorated by TNF-αInhibitors

Myśliwska, J. M., Ryba-Stanisławowska, M. E., Smardzewski, M., Słomiński, B., Myśliwiec, M., & Siebert, J. (2014) · Mediators of Inflammation · doi:10.1155/2014/946209 · Cited by 13 · see citing works

The Role of the Immune System in the Pathogenesis of Diabetic Nephropathy

Bhalla, V. (2012) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.s2-007 · Cited by 12 · see citing works

Effects of TNF-α antagonist infliximab on fructose-induced metabolic syndrome in rats

Abdelhamid, Y. A., El-Yamany, M. F., Al‐Shorbagy, M. Y., & Badary, O. A. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120969960 · Cited by 11 · see citing works

Infliximab treatment for Crohn’s disease in a patient with IgA nephropathy

Ueno, Y., Tanaka, S., Onitake, T., Hanaoka, R., Yoshioka, K., Ito, M., & Chayama, K. (2009) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-009-0112-x · Cited by 11 · see citing works

Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications

Chen, Y., Kanwar, Y. S., Chen, X., & Zhan, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230621112215 · Cited by 10 · see citing works

Mori cortex prevents kidney damage through inhibiting expression of inflammatory factors in the glomerulus in streptozocin-induced diabetic rats.

Ma, L., Ni, H., Zou, X., Yuan, Y., Luo, C., Liu, B., Wang, F., Yang, X., Chu, Y., Xu, P., et al. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8842 · Cited by 10 · see citing works

Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

Nordquist, L. (2008) · Biologics · doi:10.2147/btt.s3221 · Cited by 10 · see citing works

Cadherin and Wnt signaling pathways as key regulators in diabetic nephropathy

Tziastoudi, M., Tsezou, A., & Stefanidis, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255728 · Cited by 8 · see citing works

Mechanism of Cornus Officinalis in Treating Diabetic Kidney Disease Based on Network Pharmacology

Zhang, Y., Jin, D., Zhou, R., Yang, C., Zhang, Y.-H. H., Lian, F., & Tong, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1799106 · Cited by 8 · see citing works

Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats

Abdelrahman, A. M., Al‐Salam, S., Suleimani, Y. M. A., Ashique, M., Manoj, P., & Ali, B. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172960 · Cited by 8 · see citing works

Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice

Terai, K., Jin, D., Watase, K., Imagawa, A., & Takai, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207495 · Cited by 7 · see citing works

Immunological Approaches in the Treatment of Diabetic Nephropathy

Pour-Reza-Gholi, F., & Assadiasl, S. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998267893231016062205 · Cited by 6 · see citing works

PREVENTING DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF CURRENT PHARMACOLOGICAL APPROACHES

Dharani, B., SEBASTIAN, S., Nazrin, S., & SUBA, A. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i1.52956 · Cited by 6 · see citing works

Correlation Between Tumor Necrosis Factor Alpha and Proteinuria in Type-2 Diabetic Patients

Refat, H., Mady, G., Ghany, M. E., Seif, K., Hadidi, E. E., Elshahawy, Y., Sany, D., & Aziz, H. E. (2010) · Arab Journal of Nephrology and Transplantation · doi:10.4314/ajnt.v3i1.57598 · Cited by 6 · see citing works

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis

Aschauer, C., Perco, P., Heinzel, A., Sunzenauer, J., & Oberbauer, R. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169518 · Cited by 6 · see citing works

Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)

Poteryaeva, O. N., & Федорович, У. И. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603196 · Cited by 6 · see citing works

Tocilizumab prevents renal function of a patient with diabetic kidney disease: case report

Toriu, N., Yamanouchi, M., Hiramatsu, R., Hayami, N., Hoshino, J., Sekine, A., Kawada, M., Hasegawa, E., Suwabe, T., Sumida, K., et al. (2018) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2018.1477489 · Cited by 4 · see citing works

The relationship between urinary and plasma levels of tumor necrosis factor alpha and various stages of chronic kidney disease in patients with type II diabetes mellitus

Soleimani, A., Soleimani, M., Farzadnejad, F., & Tamadon, M.-R. (2020) · Journal of Nephropathology · doi:10.34172/jnp.2020.39 · Cited by 3 · see citing works

Tripartite motif containing 23 functions as a critical regulator in macrophages to control the pathological feature of diabetic nephropathy

Quan, W., & Wang, L. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03419-7 · Cited by 2 · see citing works

Relationship between TNF-α and diabetic nephropathy in diabetes mellitus rats

Li, X. (2007) · Shanxi Yike Daxue xuebao

Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats

Cheng, D., Liang, R., Huang, B., Hou, J., Yin, J., Zhao, T., Zhou, L., Wu, R., Qian, Y., & Wang, F. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz137 · Cited by 51 · see citing works

Protective effect of TNF-α inhibitor on diabetic nephropathy in rats

Jia-sheng, H., Ting, Z., Lu, Z., Xuan-chen, L., Ying-ying, L., Guang-yuan, Z., Qing, Z., Jian-yong, Y., Liang, R., Dong-sheng, C., et al. (2019) · DOAJ (DOAJ: Directory of Open Access Journals)

Tumor necrosis factor-α gene expression in diabetic nephropathy: Relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition

Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & Garcı́a, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 145 · see citing works

Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats

Kalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 154 · see citing works